|
1
|
Castrén E, Salminen P, Vikkula M,
Pitkäranta A and Klockars T: Inheritance patterns of infantile
hemangioma. Pediatrics. 138:e201616232016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Jong S, Itinteang T, Withers AH, Davis
PF and Tan ST: Does hypoxia play a role in infantile hemangioma?
Arch Dermatol Res. 308:219–227. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Darrow DH, Greene AK, Mancini AJ and
Nopper AJ; Section on dermatology, section on otolaryngology-head
and neck surgery, section on plastic surgery, : Diagnosis and
management of infantile hemangioma: Executive summary. Pediatrics.
136:786–791. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Léauté-Labrèze C, Hoeger P,
Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, Phillips RJ,
Caceres H, Lopez Gutierrez JC, Ballona R, et al: A randomized,
controlled trial of oral propranolol in infantile hemangioma. N
Engl J Med. 372:735–746. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang L, Yuan WE and Zheng JW:
Pharmacological therapies for infantile hemangiomas: A clinical
study in 853 consecutive patients using a standard treatment
algorithm. Sci Rep. 6:216702016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chinnadurai S, Sathe NA and Surawicz T:
Laser treatment of infantile hemangioma: A systematic review.
Lasers Surg Med. 48:221–233. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nan YH, Wang J, Wang Y, Sun PH, Han YP,
Fan L, Wang KC, Shen FJ and Wang WH: MiR-4295 promotes cell growth
in bladder cancer by targeting BTG1. Am J Transl Res. 8:4892–4901.
2016.PubMed/NCBI
|
|
8
|
Zhao F, Yang X, Xu G, Bi J, Lv R and Huo
R: Propranolol suppresses HUVEC viability, migration, VEGF
expression, and promotes apoptosis by downregulation of miR-4295. J
Cell Biochem. 120:6614–6623. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Asilian A, Mokhtari F, Kamali AS,
Abtahi-Naeini B, Nilforoushzadeh MA and Mostafaie S: Pulsed dye
laser and topical timolol gel versus pulse dye laser in treatment
of infantile hemangioma: A double-blind randomized controlled
trial. Adv Biomed Res. 4:2572015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hogeling M, Adams S and Wargon O: A
randomized controlled trial of propranolol for infantile
hemangiomas. Pediatrics. 128:e259–e266. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Achauer BM, Chang CJ and Vander Kam VM:
Management of hemangioma of infancy: Review of 245 patients. Plast
Reconstr Surg. 99:1301–1308. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ji Y, Chen S, Li K, Li L, Xu C and Xiang
B: Signaling pathways in the development of infantile hemangioma. J
Hematol Oncol. 7:132014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Greenberger S: Infantile
Hemangioma[M]//Sex and Dermatology. Springer Cham; New York, NY:
pp. 215–225. 2018
|
|
14
|
Darrow DH, Greene AK, Mancini AJ and
Nopper AJ; Section on dermatology, section on otolaryngology-head
and neck surgery, section on plastic surgery, : Diagnosis and
management of infantile hemangioma. Pediatrics. 136:e1060–e1104.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chinnadurai S, Fonnesbeck C, Snyder KM,
Sathe NA, Morad A, Likis FE and McPheeters ML: Pharmacologic
interventions for infantile hemangioma: A meta-analysis.
Pediatrics. 137:e201538962016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Léaute-Labrèze C, Boccara O,
Degrugillier-Chopinet C, Mazereeuw-Hautier J, Prey S, Lebbé G,
Gautier S, Ortis V, Lafon M, Montagne A, et al: Safety of oral
propranolol for the treatment of infantile hemangioma: A systematic
review. Pediatrics. 138:e201603532016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ng M, Knuth C, Weisbrod C and Murthy A:
Propranolol therapy for problematic infantile hemangioma. Ann Plast
Surg. 76:306–310. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hou J, Wang M, Tang H, Wang Y and Huang H:
Pingyangmycin sclerotherapy for infantile hemangiomas in oral and
maxillofacial regions: An evaluation of 66 consecutive patients.
Int J Oral Maxillofac Surg. 40:1246–1251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang Y, Li P, Xia S, Zhuo Y and Wu L:
Proapoptotic effect and the mechanism of action of pingyangmycin on
cavernous hemangiomas. Exp Ther Med. 7:473–477. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tu JB, Li QY, Jiang F, Hu XY, Ma RZ, Dong
Q, Zhang H, Pattar P and Li SX: Pingyangmycin stimulates apoptosis
in human hemangioma-derived endothelial cells through activation of
the p53 pathway. Mol Med Rep. 10:301–305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kwon SH, Choi JW, Byun SY, Kim BR, Park
KC, Youn SW, Huh CH and Na JI: Effect of early long-pulse pulsed
dye laser treatment in infantile hemangiomas. Dermatol Surg.
40:405–411. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kessels JP, Hamers ET and Ostertag JU:
Superficial hemangioma: Pulsed dye laser versus wait-and-see.
Dermatol Surg. 39:414–421. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bertoni N, Pereira LM, Severino FE, Moura
R, Yoshida WB and Reis PP: Integrative meta-analysis identifies
microRNA-regulated networks in infantile hemangioma. BMC Med Genet.
17:42016. View Article : Google Scholar : PubMed/NCBI
|
